Project Grant S10GM164795
Award Date 9/1/26
Completion Date 8/31/27
Dollars Obligated $239K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pocatello, ID 83209, USA
Similar Awards
- The National Institute of Dental and Craniofacial Research awarded Idaho State University $249,779 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to acquire a FluoView FV4000 confocal microscope for the university's Advanced Imaging Facility in Pocatello, Idaho. The FV4000 confocal microscope will replace an obsolete FV1000 unit and support high-resolution imaging and three-dimensional reconstruction of spatial organization in fixed and live cells...
- The National Institute of General Medical Sciences awarded the University of Connecticut $446,875 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop a soft, morphable hybrid electronic and microfluidic platform for drug screening in engineered human tissues. The research focuses on fabricating three integrated components: 3D multimodal electronic sensors (temperature, pressure, stimulation electrodes, and aptamer-based biomarker sensors) to...
- The National Institute of General Medical Sciences awarded $398,464 to the University of Oregon on May 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop photoresponsive biomaterials for directing the growth and differentiation of three-dimensional microphysiological tissue systems. The project focuses on creating smart, light-triggered biomaterials that provide spatial and temporal control over cell growth and differentiation in engineered tissues. The...
- The National Institute of General Medical Sciences awarded Idaho State University $169,352 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop selective cyclin-dependent kinase (CDK) 2/4/6 inhibitors for cancer treatment. The project addresses resistance to existing CDK4/6 inhibitors in metastatic breast cancer and other malignancies by targeting a rational therapeutic strategy: simultaneous inhibition of CDK2, CDK4, and CDK6. Current CDK4/6...
- The National Institute of Biomedical Imaging and Bioengineering awarded $182,558 to Iowa State University of Science and Technology on May 6, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a bioinspired drug discovery strategy for personalized combination immunoregulatory therapeutics. The research leverages the foreign body response within subcutaneous biomaterial scaffold implants to identify...
- The National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded Illinois Institute of Technology $400,000 on September 1, 2026, for development of an "organ-on-a-controller" platform that integrates real-time biosensing, predictive computational modeling, and adaptive closed-loop control to regulate human hepatocyte function in microfluidic devices. The award funds research to create a first-of-its-kind system combining three...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Rochester $226,625 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a tandem-chip microphysiological system for assessing cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in immunotherapy patients. The recipient will engineer an integrated drug development tool...
- The National Institute of General Medical Sciences awarded Oklahoma State University $373,960 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on genome evolution and design in small, single-stranded DNA phages (Microviridae). The award is structured as a Project Grant with a period of performance running through August 31, 2031. Work is performed in Oklahoma City, Oklahoma. The National Institute of General Medical Sciences...
- The National Institute of General Medical Sciences, a component of the Department of Health and Human Services National Institutes of Health, awarded 37Degrees, Inc. $360,247 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, assistance type: Project Grant). The award funds development of photoacoustic microscopy systems for non-destructive, three-dimensional imaging of live and incubated engineered tissue. The project addresses a critical gap in...
- The National Institute of General Medical Sciences awarded The University of Iowa $427,625 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop novel organoid models that resolve fibroblast-epithelial-extracellular matrix niche regulation. The funded research addresses how fibroblasts signal with and sense their environment, with particular focus on fibroblast-epithelial cell communication and interaction with the extracellular matrix. The...